NCT00864890View on ClinicalTrials.gov

A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Healthy
Interventions
DRUG

Citalopram HBr 40 mg tablets, single dose

A: Experimental Subjects received Purepac formulated products under fed conditions

DRUG

CelexaTM 40 mg tablets, single dose

B: Active comparator Subjects received Forest Labs formulated products under fed conditions

Trial Locations (1)

H4N2Y8

Algorithme Pharma Inc., Montreal

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00864890 - A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter